Executive record

Phuong Khanh (P.K.) Morrow

Director at Lantheus Holdings, Inc.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:phuong-khanh-p-k-morrowVersion: public-0As of: 2026-09-29

Not yet claimed11 published Claims4 sources
  • Director

Key Claims

Biography

Dr. Morrow is a physician-scientist and current Head of Oncology at Takeda. She has deep expertise in end-to-end clinical development in oncology.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Board service

Boards

Claims

Executive career

  1. Dates not publishedExecutive title: Head of Oncology Therapeutic Area Unit · Organization not publishedLNTH DEF 14A director slate

Claims

Conflicts and accountability

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

4 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. LNTH DEF 14A director slate

    sec filing · Source published: Mar 20, 2026 · Retrieved: Apr 28, 2026

    Supports 7 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: Apr 28, 2026
    • Board role: Board role: Director · Claim reviewed: Apr 28, 2026
    • Committee assignments: Committee assignments: Science/Innovation, Compensation · Claim reviewed: Apr 28, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: Apr 28, 2026
    • Executive company: Executive at Takeda · Claim reviewed: Apr 28, 2026
    • Executive title: Executive title: Head of Oncology Therapeutic Area Unit · Claim reviewed: Apr 28, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: Apr 28, 2026

  2. Lantheus Holdings director board source

    sec filing · Source published: Mar 20, 2026 · Retrieved: May 3, 2026

    Supports 3 claims
    • Board independence: Independent director · Claim reviewed: May 3, 2026
    • Board membership: Serves on the board of Lantheus Holdings · Claim reviewed: May 3, 2026
    • Committee assignments: No committee assignment disclosed in the cited filing · Claim reviewed: May 3, 2026

  3. Open source

    sec proxy · Source published: Mar 20, 2026 · Retrieved: Apr 28, 2026

    Supports 1 claim
    • Professional Role: Director at Lantheus Holdings, Inc. · Claim reviewed: Apr 28, 2026

  4. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of Lantheus Holdings · Claim reviewed: May 3, 2026